You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Edge Therapeutics gets Nasdaq noncompliance notice
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Investment Research Analysts Providing Greater Coverage on Inflation
Edge Therapeutics Inc. received a notice of noncompliance from Nasdaq for failing to meet the stock exchange's minimum $1 bid price listing standard.
The exchange granted Edge Therapeutics 180 calendar days, or until March 4, 2019, to regain compliance with the rule.
The Berkeley Heights, N.J.-based biotechnology said the notice has no immediate effect on its common stock which trades under the EDGE symbol on the Nasdaq Global Select Market.